In recent years, studies have found that MYH9, as a protein involved in cytoskeletal reorganization, pseudopodia formation, and migration [47], plays an important role in the progression of glioma [48] and other solid tumors [49], and MYH9 acts as an oncogene in almost all solid and hematological tumors [50]. This evidence concerns the gene MYH9 and glioma.